Alembic is rolling out Methotrexate Tablets, 2.5 mg, which are the generic of Strides' Rheumatrex Tablets.
[Read more: Alembic receives tentative OK from FDA for generic Uptravi]
Methotrexate Tablets are indicated for the treatment of adults and pediatric patients with acute lymphoblastic leukemia as part of a combination chemotherapy maintenance regimen.
Alembic will offer Methotrexate Tablets, 2.5 mg in 36-count and 100-count bottles.